- Home
- Companies
- usa oklahoma
- chemotherapy
Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Waste and Recycling
- Health and Safety
- Water and Wastewater
- Monitoring and Testing
- Environmental
- Air and Climate
- Energy
- Mining
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Agriculture
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
- Metal
- Plastics & Resins
- Pulp & Paper
- Real Estate
- Soil and Groundwater
- Construction & Construction Materials
Chemotherapy Suppliers Serving Usa Oklahoma
138 companies found
based inHamilton, ONTARIO (CANADA)
Green Cross Medico Ltd is a medical innovations company currently working in conjunction with NHS Innovations South East, Eastern Academic Health Science Network, NHS Innovations West Midlands and Glasgow Caledonian University. We are also members ...
Secure – 2 Part IV cannula dressing is a new worldwide patented design of cannula dressing that comes in 2 parts. This provides more stability by reducing movement in all directions with venous complications avoided and the possibility of ...
based inGaithersburg, MASSACHUSETTS (USA)
In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...
based inPhoenix, ARIZONA (USA)
At IntegriMedical, we develop, manufacture, and market leading-edge medical devices. As a global medical device OEM manufacturer, we are launching a new generation of needle free cartridge injectors which utilize high velocity mechanical power to ...
The Integrity Needle Free Cartidge is now available for the Veterinary market to address the following scenarios: Multiple injection procedures can minimize risk when animals move with needle in hand. Reduce needle stick injuries to staff. Easy to ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
Stem cell transplantation is a potentially curative procedure and an established therapeutic option for a number of diseases, primarily malignant diseases of the blood. In recent years, stem cell transplantation has also become an alternative ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant ...
based inBrampton, ONTARIO (CANADA)
Daniels entered the US healthcare market in 2003 as the clinical alternative for medical waste management and disposal. Challenging the long-instilled practices of medical waste being managed as a back-of-dock service with no infection risk ...
The smaller of the clinically designed chemotherapy containers, the CT22 chemotherapy sharps container is used in oncology environments and infusion bays for point-of-use chemo sharps disposal. Features a ...
based inSingapore, SINGAPORE
Esco provides standardized platforms with built-in configurations while ensuring operational parameters are not compromised. This enables the manufacture of internationally compliant pharmaceuticals, nutraceuticals, and cosmeceuticals. Esco Pharma‘s ...
based inEssen, GERMANY
Medical technology can be directed towards an indication or to everyone concerned. We orientate ourselves accordingly. Naturally, the main focus is on the patient, especially where port catheters are concerned. Port systems are intended for ...
Titan-Port AS/PT (Ascites and peritoneal therapy) is a fully implantable port catheter system providing an access facility to the peritoneal space. The set contains a titanium port chamber with a self-sealing silicone membrane and a single-lumen ...
based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
Oncoral is a novel daily irinotecan chemotherapy in development. Irinotecan chemotherapy has an established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily irinotecan tablet ...
based inMorrisville, NORTH CAROLINA (USA)
Our mission is to provide comprehensive personalized molecular solutions to inform cancer care. NantOmics, a member of the NantWorks ecosystem of companies, is a leader in molecular diagnostic testing and the first company to employ an integrated ...
Evidence-Based Treatment Intelligence for Improved Outcomes in Oncology. Cancer research is ever-evolving. Often, physicians struggle to manage overwhelming amounts of information around the risks, benefits, and trade-offs of different treatment ...
based inIllkirch-Graffenstaden, FRANCE
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...
A new generation of multifunctional oncolytic virus, TG6002 has been designed to combine the mechanism of oncolysis (targeted destruction of the cancer cell) with the production of chemotherapy (5-FU), directly into the ...
based inSanford, MAINE (USA)
Baker has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment since 1951 when Baker designed and built the first clean air workstation. Since then, we have maintained an unparalleled ...
based inSeattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
APVO436 is an optimized ADAPTIR bispecific antibody candidate designed to redirect T-cell cytotoxicity through the dual targeting of CD3, a T-cell co-receptor that promotes cytotoxicity, and CD123, a cell surface receptor highly expressed in several ...
based inSpokane, WASHINGTON (USA)
IMS has pioneered and patented technologies aimed at preventing medical device infections and treating and preventing infections associated with complex wounds. We have also developed performance coatings for various applications including ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this ...
based inSAINT-ETIENNE, FRANCE
Districlass Médical SA, a French and independent company, is one of the leader on the implantable ports European market. We are specialized in the conception, the manufacturing and the delivery of implantable medical devices, and specialized in ...
based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
based inMalvern, PENNSYLVANIA (USA)
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase ...
based inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed annually. In the U.S. this year, 1 in 6 males will develop the disease ...
based inNangang Distric, TAIWAN
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...
TLC178 is our proprietary NanoX™ formulation of the anticancer drug vinorelbine, developed for the treatment of rhabdomyosarcoma (RMS), a rare form of soft tissue sarcoma that most frequently occurs in ...